• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰因素和影响因素对血清中p105(c-erbB-2/HER-2)癌蛋白片段分析的影响

Effects of interfering and influencing factors on the analyses of p105 (c-erbB-2/HER-2) oncoprotein fragment in serum.

作者信息

Mielke S, Meden H, Raab T, Wuttke W, Kuhn W

机构信息

Department of Obstetrics and Gynecology, University of Göttingen, Germany.

出版信息

Anticancer Res. 1997 Jul-Aug;17(4B):3125-7.

PMID:9329617
Abstract

BACKGROUND

The 105 kDa extracellular domain of c-erbB-2 encoded protein p185 is detectable in serum. Elevated p105 serum levels were found in patients with breast and ovarian cancer and in pregnancy. The effects of interfering and influencing factors on the measurement are still unclear.

MATERIAL AND METHODS

We used an ELISA based on the monoclonal capture antibody OD-3 and investigated possible interfering factors, like changing transporting and storing conditions of blood and serum samples. In order to evaluate a normal range of p105 serum values we examined 71 healthy women.

RESULTS

In our tests we found no influence on the reproducibility of results by changing transporting and storing conditions. We could not find any dependency of p105 serum values on the menstrual cycle or the age of controls. Postmenopausal women showed significantly higher serum values than premenopausal women (p = 0.0127).

CONCLUSIONS

Clinical interpretation of female p105 serum values requires comparison with normal ranges when considering the menopause as an influencing factor.

摘要

背景

c-erbB-2编码蛋白p185的105 kDa细胞外结构域可在血清中检测到。在乳腺癌和卵巢癌患者以及孕期女性中发现血清p105水平升高。干扰因素和影响因素对该测量的作用仍不清楚。

材料与方法

我们使用基于单克隆捕获抗体OD-3的酶联免疫吸附测定法(ELISA),并研究了可能的干扰因素,如血液和血清样本运输及储存条件的改变。为评估p105血清值的正常范围,我们检测了71名健康女性。

结果

在我们的测试中,发现改变运输和储存条件对结果的可重复性没有影响。我们未发现p105血清值与月经周期或对照者年龄之间存在任何相关性。绝经后女性的血清值显著高于绝经前女性(p = 0.0127)。

结论

在将绝经视为影响因素时,对女性p105血清值进行临床解读需要与正常范围进行比较。

相似文献

1
Effects of interfering and influencing factors on the analyses of p105 (c-erbB-2/HER-2) oncoprotein fragment in serum.干扰因素和影响因素对血清中p105(c-erbB-2/HER-2)癌蛋白片段分析的影响
Anticancer Res. 1997 Jul-Aug;17(4B):3125-7.
2
Serum levels of the c-erbB-2 (HER2/neu) encoded oncoprotein fragment p105 in normal pregnancies.正常妊娠中c-erbB-2(HER2/neu)编码的癌蛋白片段p105的血清水平。
In Vivo. 1997 Jan-Feb;11(1):51-4.
3
Detection of p105 (c-erbB-2, HER2/neu) serum levels by a new ELISA in patients with ovarian carcinoma.采用新型酶联免疫吸附测定法检测卵巢癌患者血清中p105(c-erbB-2,HER2/neu)水平。
Anticancer Res. 1998 Jul-Aug;18(4B):2891-4.
4
Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.口腔鳞状细胞癌患者血清中c-erbB-2癌基因产物水平升高。
J Oral Pathol Med. 2004 Nov;33(10):589-94. doi: 10.1111/j.1600-0714.2004.00209.x.
5
Prognostic significance of p105 (c-erbB-2 HER2/neu) serum levels in patients with ovarian cancer.
Anticancer Res. 1997 Jan-Feb;17(1B):757-60.
6
Hormonal treatment with sex steroids in women is associated with lower p105 serum concentrations.
Anticancer Res. 1997 Jul-Aug;17(4B):3075-7.
7
The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study.乳腺癌女性唾液和血清中可溶性c-erbB-2的存在:一项初步研究。
Clin Cancer Res. 2000 Jun;6(6):2363-70.
8
Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.HER-2/neu细胞外结构域(ECD)对转移性乳腺癌化疗患者血清的预后及预测影响
Breast Cancer Res Treat. 2004 Jul;86(1):9-18. doi: 10.1023/B:BREA.0000032919.83803.48.
9
Clinical significance of soluble c-erbB-2 levels in the serum and urine of patients with gastric cancer.胃癌患者血清和尿液中可溶性c-erbB-2水平的临床意义
Anticancer Res. 2002 Sep-Oct;22(5):3061-5.
10
Overexpression of c-erbB-2 oncoprotein and associated pathobiological factors in invasive primary breast cancer.
Indian J Exp Biol. 2004 Mar;42(3):253-8.

引用本文的文献

1
Diagnostic Significance of CA15-3 with Combination of HER-2/neu Values at 85th Percentiles in Breast Cancer.CA15-3与第85百分位数HER-2/neu值联合检测在乳腺癌中的诊断意义
Indian J Clin Biochem. 2013 Apr;28(2):136-40. doi: 10.1007/s12291-012-0288-6. Epub 2012 Dec 11.